カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の糖化ヘモグロビン制御市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Glycated Hemoglobin Control Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19358）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19358
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の糖化ヘモグロビン制御市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

糖化ヘモグロビン制御市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の糖化ヘモグロビン制御の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

糖化ヘモグロビン制御市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・CRL-1:2mL×1、CRL-2:2mL×1、CRL-1:2mL×3、CRL-2:2mL×3、その他

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界の糖化ヘモグロビン制御市場の主要な市場プレーヤーは以下のとおりです。
・Tosoh、Hitachi、Siemens、Abbott、Canterbury Scientific Ltd.、JEOL Ltd.、Trinity Biotech、SEKISUI CHEMICAL CO.,LTD、Sysmex Corporation、Randox Laboratories

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、糖化ヘモグロビン制御製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な糖化ヘモグロビン制御メーカーの企業概要、2019年～2022年までの糖化ヘモグロビン制御の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な糖化ヘモグロビン制御メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別糖化ヘモグロビン制御の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの糖化ヘモグロビン制御の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での糖化ヘモグロビン制御市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および糖化ヘモグロビン制御の産業チェーンを掲載しています。
・第13、14、15章では、糖化ヘモグロビン制御の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 糖化ヘモグロビン制御の概要
- 種類別分析（2017年vs2021年vs2028年）：CRL-1:2mL×1、CRL-2:2mL×1、CRL-1:2mL×3、CRL-2:2mL×3、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界の糖化ヘモグロビン制御市場規模・予測
- 世界の糖化ヘモグロビン制御生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Tosoh、Hitachi、Siemens、Abbott、Canterbury Scientific Ltd.、JEOL Ltd.、Trinity Biotech、SEKISUI CHEMICAL CO.,LTD、Sysmex Corporation、Randox Laboratories
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：CRL-1:2mL×1、CRL-2:2mL×1、CRL-1:2mL×3、CRL-2:2mL×3、その他
・用途別分析2017年-2028年：病院、診療所、その他
・糖化ヘモグロビン制御の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・糖化ヘモグロビン制御のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・糖化ヘモグロビン制御のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・糖化ヘモグロビン制御の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・糖化ヘモグロビン制御の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Glycated Hemoglobin Control market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Glycated Hemoglobin Control market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Glycated Hemoglobin Control global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While CRL-1:2mL×1 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Glycated Hemoglobin Control include Tosoh, Hitachi, Siemens, Abbott, and Canterbury Scientific Ltd., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Glycated Hemoglobin Control market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CRL-1:2mL×1
CRL-2:2mL×1
CRL-1:2mL×3
CRL-2:2mL×3
Other
Market segment by Application can be divided into
Hospitals
Clinics
Other
The key market players for global Glycated Hemoglobin Control market are listed below:
Tosoh
Hitachi
Siemens
Abbott
Canterbury Scientific Ltd.
JEOL Ltd.
Trinity Biotech
SEKISUI CHEMICAL CO.,LTD
Sysmex Corporation
Randox Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glycated Hemoglobin Control product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glycated Hemoglobin Control, with price, sales, revenue and global market share of Glycated Hemoglobin Control from 2019 to 2022.
Chapter 3, the Glycated Hemoglobin Control competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glycated Hemoglobin Control breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Glycated Hemoglobin Control market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Glycated Hemoglobin Control.
Chapter 13, 14, and 15, to describe Glycated Hemoglobin Control sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Glycated Hemoglobin Control Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glycated Hemoglobin Control Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 CRL-1:2mL×1
1.2.3 CRL-2:2mL×1
1.2.4 CRL-1:2mL×3
1.2.5 CRL-2:2mL×3
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Glycated Hemoglobin Control Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Glycated Hemoglobin Control Market Size & Forecast
1.4.1 Global Glycated Hemoglobin Control Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Glycated Hemoglobin Control Sales in Volume (2017-2028)
1.4.3 Global Glycated Hemoglobin Control Price (2017-2028)
1.5 Global Glycated Hemoglobin Control Production Capacity Analysis
1.5.1 Global Glycated Hemoglobin Control Total Production Capacity (2017-2028)
1.5.2 Global Glycated Hemoglobin Control Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glycated Hemoglobin Control Market Drivers
1.6.2 Glycated Hemoglobin Control Market Restraints
1.6.3 Glycated Hemoglobin Control Trends Analysis
2 Manufacturers Profiles
2.1 Tosoh
2.1.1 Tosoh Details
2.1.2 Tosoh Major Business
2.1.3 Tosoh Glycated Hemoglobin Control Product and Services
2.1.4 Tosoh Glycated Hemoglobin Control Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Hitachi
2.2.1 Hitachi Details
2.2.2 Hitachi Major Business
2.2.3 Hitachi Glycated Hemoglobin Control Product and Services
2.2.4 Hitachi Glycated Hemoglobin Control Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Siemens
2.3.1 Siemens Details
2.3.2 Siemens Major Business
2.3.3 Siemens Glycated Hemoglobin Control Product and Services
2.3.4 Siemens Glycated Hemoglobin Control Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Glycated Hemoglobin Control Product and Services
2.4.4 Abbott Glycated Hemoglobin Control Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Canterbury Scientific Ltd.
2.5.1 Canterbury Scientific Ltd. Details
2.5.2 Canterbury Scientific Ltd. Major Business
2.5.3 Canterbury Scientific Ltd. Glycated Hemoglobin Control Product and Services
2.5.4 Canterbury Scientific Ltd. Glycated Hemoglobin Control Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 JEOL Ltd.
2.6.1 JEOL Ltd. Details
2.6.2 JEOL Ltd. Major Business
2.6.3 JEOL Ltd. Glycated Hemoglobin Control Product and Services
2.6.4 JEOL Ltd. Glycated Hemoglobin Control Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Trinity Biotech
2.7.1 Trinity Biotech Details
2.7.2 Trinity Biotech Major Business
2.7.3 Trinity Biotech Glycated Hemoglobin Control Product and Services
2.7.4 Trinity Biotech Glycated Hemoglobin Control Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 SEKISUI CHEMICAL CO.,LTD
2.8.1 SEKISUI CHEMICAL CO.,LTD Details
2.8.2 SEKISUI CHEMICAL CO.,LTD Major Business
2.8.3 SEKISUI CHEMICAL CO.,LTD Glycated Hemoglobin Control Product and Services
2.8.4 SEKISUI CHEMICAL CO.,LTD Glycated Hemoglobin Control Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sysmex Corporation
2.9.1 Sysmex Corporation Details
2.9.2 Sysmex Corporation Major Business
2.9.3 Sysmex Corporation Glycated Hemoglobin Control Product and Services
2.9.4 Sysmex Corporation Glycated Hemoglobin Control Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Randox Laboratories
2.10.1 Randox Laboratories Details
2.10.2 Randox Laboratories Major Business
2.10.3 Randox Laboratories Glycated Hemoglobin Control Product and Services
2.10.4 Randox Laboratories Glycated Hemoglobin Control Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Glycated Hemoglobin Control Breakdown Data by Manufacturer
3.1 Global Glycated Hemoglobin Control Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Glycated Hemoglobin Control Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Glycated Hemoglobin Control
3.4 Market Concentration Rate
3.4.1 Top 3 Glycated Hemoglobin Control Manufacturer Market Share in 2021
3.4.2 Top 6 Glycated Hemoglobin Control Manufacturer Market Share in 2021
3.5 Global Glycated Hemoglobin Control Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Glycated Hemoglobin Control Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glycated Hemoglobin Control Market Size by Region
4.1.1 Global Glycated Hemoglobin Control Sales in Volume by Region (2017-2028)
4.1.2 Global Glycated Hemoglobin Control Revenue by Region (2017-2028)
4.2 North America Glycated Hemoglobin Control Revenue (2017-2028)
4.3 Europe Glycated Hemoglobin Control Revenue (2017-2028)
4.4 Asia-Pacific Glycated Hemoglobin Control Revenue (2017-2028)
4.5 South America Glycated Hemoglobin Control Revenue (2017-2028)
4.6 Middle East and Africa Glycated Hemoglobin Control Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Glycated Hemoglobin Control Sales in Volume by Type (2017-2028)
5.2 Global Glycated Hemoglobin Control Revenue by Type (2017-2028)
5.3 Global Glycated Hemoglobin Control Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Glycated Hemoglobin Control Sales in Volume by Application (2017-2028)
6.2 Global Glycated Hemoglobin Control Revenue by Application (2017-2028)
6.3 Global Glycated Hemoglobin Control Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Glycated Hemoglobin Control Sales by Type (2017-2028)
7.2 North America Glycated Hemoglobin Control Sales by Application (2017-2028)
7.3 North America Glycated Hemoglobin Control Market Size by Country
7.3.1 North America Glycated Hemoglobin Control Sales in Volume by Country (2017-2028)
7.3.2 North America Glycated Hemoglobin Control Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Glycated Hemoglobin Control Sales by Type (2017-2028)
8.2 Europe Glycated Hemoglobin Control Sales by Application (2017-2028)
8.3 Europe Glycated Hemoglobin Control Market Size by Country
8.3.1 Europe Glycated Hemoglobin Control Sales in Volume by Country (2017-2028)
8.3.2 Europe Glycated Hemoglobin Control Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Glycated Hemoglobin Control Sales by Type (2017-2028)
9.2 Asia-Pacific Glycated Hemoglobin Control Sales by Application (2017-2028)
9.3 Asia-Pacific Glycated Hemoglobin Control Market Size by Region
9.3.1 Asia-Pacific Glycated Hemoglobin Control Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Glycated Hemoglobin Control Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Glycated Hemoglobin Control Sales by Type (2017-2028)
10.2 South America Glycated Hemoglobin Control Sales by Application (2017-2028)
10.3 South America Glycated Hemoglobin Control Market Size by Country
10.3.1 South America Glycated Hemoglobin Control Sales in Volume by Country (2017-2028)
10.3.2 South America Glycated Hemoglobin Control Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glycated Hemoglobin Control Sales by Type (2017-2028)
11.2 Middle East & Africa Glycated Hemoglobin Control Sales by Application (2017-2028)
11.3 Middle East & Africa Glycated Hemoglobin Control Market Size by Country
11.3.1 Middle East & Africa Glycated Hemoglobin Control Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Glycated Hemoglobin Control Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Glycated Hemoglobin Control and Key Manufacturers
12.2 Manufacturing Costs Percentage of Glycated Hemoglobin Control
12.3 Glycated Hemoglobin Control Production Process
12.4 Glycated Hemoglobin Control Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Glycated Hemoglobin Control Typical Distributors
13.3 Glycated Hemoglobin Control Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Glycated Hemoglobin Control Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Glycated Hemoglobin Control Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Tosoh Basic Information, Manufacturing Base and Competitors
Table 4. Tosoh Major Business
Table 5. Tosoh Glycated Hemoglobin Control Product and Services
Table 6. Tosoh Glycated Hemoglobin Control Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Hitachi Basic Information, Manufacturing Base and Competitors
Table 8. Hitachi Major Business
Table 9. Hitachi Glycated Hemoglobin Control Product and Services
Table 10. Hitachi Glycated Hemoglobin Control Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Siemens Basic Information, Manufacturing Base and Competitors
Table 12. Siemens Major Business
Table 13. Siemens Glycated Hemoglobin Control Product and Services
Table 14. Siemens Glycated Hemoglobin Control Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Glycated Hemoglobin Control Product and Services
Table 18. Abbott Glycated Hemoglobin Control Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Canterbury Scientific Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. Canterbury Scientific Ltd. Major Business
Table 21. Canterbury Scientific Ltd. Glycated Hemoglobin Control Product and Services
Table 22. Canterbury Scientific Ltd. Glycated Hemoglobin Control Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. JEOL Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. JEOL Ltd. Major Business
Table 25. JEOL Ltd. Glycated Hemoglobin Control Product and Services
Table 26. JEOL Ltd. Glycated Hemoglobin Control Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Trinity Biotech Basic Information, Manufacturing Base and Competitors
Table 28. Trinity Biotech Major Business
Table 29. Trinity Biotech Glycated Hemoglobin Control Product and Services
Table 30. Trinity Biotech Glycated Hemoglobin Control Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. SEKISUI CHEMICAL CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 32. SEKISUI CHEMICAL CO.,LTD Major Business
Table 33. SEKISUI CHEMICAL CO.,LTD Glycated Hemoglobin Control Product and Services
Table 34. SEKISUI CHEMICAL CO.,LTD Glycated Hemoglobin Control Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Sysmex Corporation Major Business
Table 37. Sysmex Corporation Glycated Hemoglobin Control Product and Services
Table 38. Sysmex Corporation Glycated Hemoglobin Control Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Randox Laboratories Basic Information, Manufacturing Base and Competitors
Table 40. Randox Laboratories Major Business
Table 41. Randox Laboratories Glycated Hemoglobin Control Product and Services
Table 42. Randox Laboratories Glycated Hemoglobin Control Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Glycated Hemoglobin Control Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Glycated Hemoglobin Control Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Glycated Hemoglobin Control, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Glycated Hemoglobin Control Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Glycated Hemoglobin Control Production Site of Key Manufacturer
Table 48. Glycated Hemoglobin Control New Entrant and Capacity Expansion Plans
Table 49. Glycated Hemoglobin Control Mergers & Acquisitions in the Past Five Years
Table 50. Global Glycated Hemoglobin Control Sales by Region (2017-2022) & (K Units)
Table 51. Global Glycated Hemoglobin Control Sales by Region (2023-2028) & (K Units)
Table 52. Global Glycated Hemoglobin Control Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Glycated Hemoglobin Control Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Glycated Hemoglobin Control Sales by Type (2017-2022) & (K Units)
Table 55. Global Glycated Hemoglobin Control Sales by Type (2023-2028) & (K Units)
Table 56. Global Glycated Hemoglobin Control Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Glycated Hemoglobin Control Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Glycated Hemoglobin Control Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Glycated Hemoglobin Control Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Glycated Hemoglobin Control Sales by Application (2017-2022) & (K Units)
Table 61. Global Glycated Hemoglobin Control Sales by Application (2023-2028) & (K Units)
Table 62. Global Glycated Hemoglobin Control Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Glycated Hemoglobin Control Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Glycated Hemoglobin Control Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Glycated Hemoglobin Control Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Glycated Hemoglobin Control Sales by Country (2017-2022) & (K Units)
Table 67. North America Glycated Hemoglobin Control Sales by Country (2023-2028) & (K Units)
Table 68. North America Glycated Hemoglobin Control Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Glycated Hemoglobin Control Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Glycated Hemoglobin Control Sales by Type (2017-2022) & (K Units)
Table 71. North America Glycated Hemoglobin Control Sales by Type (2023-2028) & (K Units)
Table 72. North America Glycated Hemoglobin Control Sales by Application (2017-2022) & (K Units)
Table 73. North America Glycated Hemoglobin Control Sales by Application (2023-2028) & (K Units)
Table 74. Europe Glycated Hemoglobin Control Sales by Country (2017-2022) & (K Units)
Table 75. Europe Glycated Hemoglobin Control Sales by Country (2023-2028) & (K Units)
Table 76. Europe Glycated Hemoglobin Control Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Glycated Hemoglobin Control Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Glycated Hemoglobin Control Sales by Type (2017-2022) & (K Units)
Table 79. Europe Glycated Hemoglobin Control Sales by Type (2023-2028) & (K Units)
Table 80. Europe Glycated Hemoglobin Control Sales by Application (2017-2022) & (K Units)
Table 81. Europe Glycated Hemoglobin Control Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Glycated Hemoglobin Control Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Glycated Hemoglobin Control Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Glycated Hemoglobin Control Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Glycated Hemoglobin Control Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Glycated Hemoglobin Control Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Glycated Hemoglobin Control Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Glycated Hemoglobin Control Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Glycated Hemoglobin Control Sales by Application (2023-2028) & (K Units)
Table 90. South America Glycated Hemoglobin Control Sales by Country (2017-2022) & (K Units)
Table 91. South America Glycated Hemoglobin Control Sales by Country (2023-2028) & (K Units)
Table 92. South America Glycated Hemoglobin Control Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Glycated Hemoglobin Control Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Glycated Hemoglobin Control Sales by Type (2017-2022) & (K Units)
Table 95. South America Glycated Hemoglobin Control Sales by Type (2023-2028) & (K Units)
Table 96. South America Glycated Hemoglobin Control Sales by Application (2017-2022) & (K Units)
Table 97. South America Glycated Hemoglobin Control Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Glycated Hemoglobin Control Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Glycated Hemoglobin Control Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Glycated Hemoglobin Control Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Glycated Hemoglobin Control Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Glycated Hemoglobin Control Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Glycated Hemoglobin Control Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Glycated Hemoglobin Control Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Glycated Hemoglobin Control Sales by Application (2023-2028) & (K Units)
Table 106. Glycated Hemoglobin Control Raw Material
Table 107. Key Manufacturers of Glycated Hemoglobin Control Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Glycated Hemoglobin Control Typical Distributors
Table 111. Glycated Hemoglobin Control Typical Customers
List of Figures
Figure 1. Glycated Hemoglobin Control Picture
Figure 2. Global Glycated Hemoglobin Control Revenue Market Share by Type in 2021
Figure 3. CRL-1:2mL×1
Figure 4. CRL-2:2mL×1
Figure 5. CRL-1:2mL×3
Figure 6. CRL-2:2mL×3
Figure 7. Other
Figure 8. Global Glycated Hemoglobin Control Revenue Market Share by Application in 2021
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Other
Figure 12. Global Glycated Hemoglobin Control Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Glycated Hemoglobin Control Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Glycated Hemoglobin Control Sales (2017-2028) & (K Units)
Figure 15. Global Glycated Hemoglobin Control Price (2017-2028) & (US$/Unit)
Figure 16. Global Glycated Hemoglobin Control Production Capacity (2017-2028) & (K Units)
Figure 17. Global Glycated Hemoglobin Control Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Glycated Hemoglobin Control Market Drivers
Figure 19. Glycated Hemoglobin Control Market Restraints
Figure 20. Glycated Hemoglobin Control Market Trends
Figure 21. Global Glycated Hemoglobin Control Sales Market Share by Manufacturer in 2021
Figure 22. Global Glycated Hemoglobin Control Revenue Market Share by Manufacturer in 2021
Figure 23. Glycated Hemoglobin Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Glycated Hemoglobin Control Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Glycated Hemoglobin Control Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Glycated Hemoglobin Control Sales Market Share by Region (2017-2028)
Figure 27. Global Glycated Hemoglobin Control Revenue Market Share by Region (2017-2028)
Figure 28. North America Glycated Hemoglobin Control Revenue (2017-2028) & (USD Million)
Figure 29. Europe Glycated Hemoglobin Control Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Glycated Hemoglobin Control Revenue (2017-2028) & (USD Million)
Figure 31. South America Glycated Hemoglobin Control Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Glycated Hemoglobin Control Revenue (2017-2028) & (USD Million)
Figure 33. Global Glycated Hemoglobin Control Sales Market Share by Type (2017-2028)
Figure 34. Global Glycated Hemoglobin Control Revenue Market Share by Type (2017-2028)
Figure 35. Global Glycated Hemoglobin Control Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Glycated Hemoglobin Control Sales Market Share by Application (2017-2028)
Figure 37. Global Glycated Hemoglobin Control Revenue Market Share by Application (2017-2028)
Figure 38. Global Glycated Hemoglobin Control Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Glycated Hemoglobin Control Sales Market Share by Type (2017-2028)
Figure 40. North America Glycated Hemoglobin Control Sales Market Share by Application (2017-2028)
Figure 41. North America Glycated Hemoglobin Control Sales Market Share by Country (2017-2028)
Figure 42. North America Glycated Hemoglobin Control Revenue Market Share by Country (2017-2028)
Figure 43. United States Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Glycated Hemoglobin Control Sales Market Share by Type (2017-2028)
Figure 47. Europe Glycated Hemoglobin Control Sales Market Share by Application (2017-2028)
Figure 48. Europe Glycated Hemoglobin Control Sales Market Share by Country (2017-2028)
Figure 49. Europe Glycated Hemoglobin Control Revenue Market Share by Country (2017-2028)
Figure 50. Germany Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Glycated Hemoglobin Control Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Glycated Hemoglobin Control Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Glycated Hemoglobin Control Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Glycated Hemoglobin Control Revenue Market Share by Region (2017-2028)
Figure 59. China Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Glycated Hemoglobin Control Sales Market Share by Type (2017-2028)
Figure 66. South America Glycated Hemoglobin Control Sales Market Share by Application (2017-2028)
Figure 67. South America Glycated Hemoglobin Control Sales Market Share by Country (2017-2028)
Figure 68. South America Glycated Hemoglobin Control Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Glycated Hemoglobin Control Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Glycated Hemoglobin Control Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Glycated Hemoglobin Control Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Glycated Hemoglobin Control Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Glycated Hemoglobin Control Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Glycated Hemoglobin Control in 2021
Figure 80. Manufacturing Process Analysis of Glycated Hemoglobin Control
Figure 81. Glycated Hemoglobin Control Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の糖化ヘモグロビン検査装置市場2022年：市場規模予測（～2028年）
  • 世界の携帯型ヘモグロビンモニター市場2022年：市場規模予測（～2028年）
  • 世界の無線ヘモグロビンモニター市場2022年：市場規模予測（～2028年）
  • 世界のPOCグリコシル化ヘモグロビン分析装置市場2022年：市場規模予測（～2028年）
  • 世界の携帯型ヘモグロビン分析装置市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19358 )"世界の糖化ヘモグロビン制御市場2022年：市場規模予測（～2028年）" (英文：Global Glycated Hemoglobin Control Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。